CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-05-10 | SCHAFER GREGORY W Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2011-05-10 | Kazam Joshua A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2011-05-10 | KASH PETER M Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2011-05-10 | Mieyal Paul A Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2011-05-10 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2011-05-10 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2011-04-18 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2011-01-03 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +27,192 | 128,442 | ||
| 2011-01-03 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +18,128 | 85,628 | ||
| 2010-12-17 | Lieu Hsiao VP, Clinical Research | Grant or award · Stock Option (Right to Buy) | +25,000 | 46,623 | ||
| 2010-07-26 | Mieyal Paul A Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2010-07-26 | Litvack Frank Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2010-07-26 | Kazam Joshua A Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2010-07-26 | KASH PETER M Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2010-07-26 | GRANADILLO PEDRO P Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2010-07-26 | Belldegrun Arie Director | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2010-07-26 | Evans Daron Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2010-07-26 | BREWER RICHARD B Executive Chairman | Grant or award · Stock Option (Right to Buy) | +900,000 | 900,000 | ||
| 2010-07-26 | SCHAFER GREGORY W Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2010-07-21 | BREWER RICHARD B Executive Chairman | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 |
Page 26 of 31 · 605 trades